| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |